Greenline Partners, LLC Viatris Inc Transaction History

Greenline Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$12.09 - $14.68 $175,196 - $212,727	-14,491 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $3,100 - $3,540	-234 Reduced 1.59%	14,491 $196,000
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $20,570 - $25,613	-1,586 Reduced 9.72%	14,725 $210,000
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $221,666 - $302,405	16,311 New	16,311 $228,000

1,117

945M

4.55M

2.81M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Greenline Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Greenline Partners, LLC with notifications on news.